| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 84 / 428 | 80th | Q1 |
| Cancer Research | 75 / 233 | 68th | Q2 |
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Advances in Cancer Research
Advances in Cancer Research is Scopus-indexed (Q1, CiteScore 7). Published by Academic Press Inc..
Checked against the index lists dated .
ISSN 0065-230XVerify ISSN ↗2162-5557Verify ISSN ↗
Publisher: Academic Press Inc.
Cost to publish: No APC data — check the publisher
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is Advances in Cancer Research indexed in Scopus?
Yes — actively indexed in Scopus, coverage 1969–present (also 1967, 1962–1965, 1958, 1953–1956), best quartile Q1, CiteScore 7.
What quartile is Advances in Cancer Research in Scopus?
Advances in Cancer Research is Q1 in Oncology (rank 84 of 428) and Q2 in Cancer Research (rank 75 of 233), by CiteScore 2025.
What is the impact factor of Advances in Cancer Research?
Advances in Cancer Research is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 7, quartile Q1, 80th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.728, quartile Q1, with an H-index of 120.
Who publishes Advances in Cancer Research and what is its ISSN?
Advances in Cancer Research is published by Academic Press Inc. Its print ISSN is 0065-230X and its online ISSN is 2162-5557.
Is Advances in Cancer Research in Web of Science?
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Is Advances in Cancer Research open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
How well cited is Advances in Cancer Research? — open metrics via OpenAlex
Advances in Cancer Research has an h-index of 174 and a 2-year mean of 1.77 citations per paper (OpenAlex). Its Scopus CiteScore is 7, quartile Q1. On 2-year citations it ranks #218 of 424 Scopus journals in Oncology.
Advances in Cancer Research published 59 papers in 2025; its busiest recent year was 2022 with 64. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Are there integrity warnings for Advances in Cancer Research? — indicators, not proof of misconduct
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusActive
- Retracted papers None recorded
- Problematic Paper Screener flags None flagged
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journalsIndex data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.